Effect of adenosine and adenosine-5'-triphosphate on atrioventricular conduction in patients

This study was carried out to further elucidate the effects of adenosine and adenosine-5'-triphosphate (ATP) on atrioventricular (AV) conduction in patients. Adenosine (0.24 mg/kg) and ATP (0.28 mg/kg) were administered intravenously to 37 patients undergoing intracardiac electrophysiologic evaluation. Both adenosine and ATP depressed AV conduction by lengthening the atrial to His bundle (AH) interval. The effects of adenosine and ATP after rapid intravenous bolus administration were fast in onset (15 +/- 0.5 and 15 +/- 1.5 s, respectively), but transient in duration (10.5 +/- 0.5 s for ATP and 17 +/- 3 s for adenosine). Although muscarinic blockade with 0.04 mg/kg atropine shortened the AH interval from a control value of 123 +/- 12 to 74 +/- 4 ms, it did not modify the effects of adenosine or ATP, or both (that is, latency and duration of the effects were not significantly different from before atropine administration). In contrast, aminophylline, a competitive antagonist of adenosine, completely prevented the effects of adenosine and ATP. Aminophylline alone also shortened the AH interval from a control value of 98 +/- 9 to 74 +/- 9 ms. This decrease was blocked by propranolol (0.1 mg/kg), whereas propranolol did not influence the ability of aminophylline to antagonize the effects of adenosine or ATP, or both. Thus, the catecholamines released by aminophylline are unlikely to account for the ability of aminophylline to antagonize the effects of adenosine and ATP. In conclusion, these findings indicate that intravenously administered adenosine and ATP are equally effective in producing AV block that is antagonized by aminophylline but not by atropine.

This article has been cited by other articles:

				J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF]

				H. Hase, N. Joki, H. Ishikawa, H. Fukuda, Y. Imamura, T. Saijyo, Y. Tanaka, Y. Takahashi, Y. Inishi, M. Nakamura, et al. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1161 - 1167. [Abstract] [Full Text] [PDF]

				A. Jeremias, S. D. Filardo, R. J. Whitbourn, R. S. Kernoff, A. C. Yeung, P. J. Fitzgerald, and P. G. Yock Effects of Intravenous and Intracoronary Adenosine 5'-Triphosphate as Compared With Adenosine on Coronary Flow and Pressure Dynamics Circulation, January 25, 2000; 101(3): 318 - 323. [Abstract] [Full Text] [PDF]

				M Brignole, G Gaggioli, C Menozzi, A Del Rosso, S Costa, A Bartoletti, N Bottoni, and G Lolli Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope Heart, January 1, 2000; 83(1): 24 - 28. [Abstract] [Full Text] [PDF]

				G A Ng, W Martin, and A C Rankin Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy Heart, August 1, 1999; 82(2): 163 - 169. [Abstract] [Full Text] [PDF]

				J V De Giovanni, R A Edgar, and A Cranston Adenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease Heart, October 1, 1998; 80(4): 330 - 333. [Abstract] [Full Text]

				M. Brignole, G. Gaggioli, C. Menozzi, L. Gianfranchi, A. Bartoletti, N. Bottoni, G. Lolli, D. Oddone, D. Attilio Del Rosso, and G. Pellinghelli Adenosine-Induced Atrioventricular Block in Patients With Unexplained Syncope : The Diagnostic Value of ATP Testing Circulation, December 2, 1997; 96(11): 3921 - 3927. [Abstract] [Full Text]

				J. B. Conti, L. Belardinelli, D. B. Utterback, and A. B. Curtis Endogenous Adenosine Is an Antiarrhythmic Agent Circulation, March 15, 1995; 91(6): 1761 - 1767. [Abstract] [Full Text]